Work

Glycemic control after vitamin D repletion in type 1 diabetes mellitus pediatric population: a clinical trial intervention

Year: 2015
Type: dissertation
Study design: Study Protocol
Abstract: Background. It has been discovered that 3% of the human genome is regulated directly or indirectly by the vitamin D and that with adequate levels of vitamin D, if the established relations with cancer and others are correct, death rate would drop a 7%. Several studies show a high prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes, ranging between 43 and 91%. Currently, the screening and treatment of vitamin D deficiency is not considered standard of care for T1DM patients.\n\nJustification. Vitamin D is required for and improves the production of insulin, and also improves insulin sensitivity. On this basis, vitamin D repletion should improve glycemic control in T1DM patients.\n\nPurpose. The goal of the present work is to evaluate improvement in glycemic control after vitamin D repletion in T1DM pediatric population with vitamin D levels ranging below normality. Glycemic control will be evaluated on basis of glycated hemoglobin.\n\nDesign. This protocol is for a multicenter, prospective, randomized, double blind, placebo controlled 12 months clinical trial in pediatric patients with T1DM.\n\nParticipants. T1DM pediatric population with vitamin D levels ranging below sufficiency from Pediatric Endocrinology Unit in Hospital Josep Trueta, Hospital de Palamós, Hospital de Calella, Hospital de Figueres and Hospital de Blanes.\n\nMethod. 158 T1DM patients with vitamin D levels below sufficiency (<30 μg/ml) will be randomized into treatment or placebo group (1:1) receiving 25.000 IU of cholecalciferol or placebo respectively. Measurements will be collected at month 0, 6 and 12, coinciding with T1DM follow up visit
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W2530705561
Cites:
Cited by:
Related to: 10